Evidence based pediatrics - part 3 ppt
Evidence based pediatrics - part 3 ppt
... than 43 C for 60 minutes. In the sec-
ond part of the study, 32 individuals received a 1-hour treatment with steam ( 43 C) and were
compared with 36 who received room air (20 to 24°C). A 7-day ... Pediatr
Infect Dis J 1994; 13: 585–9.
77. Cetron M, Breiman R, Jorgensen J. Multi-site population -based surveillance for drug-resistant Strep-
tococcus pneumoniae (DRSP) [abstract C-2 83] , 97...
Evidence based pediatrics - part 1 ppt
... Sci 1987;92 :30 1-1 4.
72. Annas GJ. Women and children first. N Engl J Med 1995 ;33 3:164 7-5 1.
73. Carty EM, Bradley CF. A randomised, controlled evaluation of early postpartum hospital dis-
charge. ... mea-
surement. Pediatrics 1998;101:221–8.
34 Evidence- Based Pediatrics
EVIDENCE- BASED
PEDIATRICS
William Feldman, MD, FRCPC
Professor Emeritus of Pediatrics
University...
Evidence based pediatrics - part 6 pptx
... Commission of Pediatrics of the International League against Epilepsy.
Restrictions for children with epilepsy. Epilepsia 1997 ;38 :1054–7.
240 Evidence- Based Pediatrics
230 Evidence- Based Pediatrics
Table ... Com-
pany; 19 93. p. 198–208.
42. Loening-Baucke V. Constipation in early childhood: patient characteristics, treatment and long-
term follow-up. Gut 19 93; 34:1400–4.
43...
Evidence based pediatrics - part 10 ppt
... anaphylaxis, 33 8
and diagnosis of immediate
hypersensitivity, 33 0 -3 33
environmental, 33 0
food, 32 7 -3 29
penicillin, and cross-
reactions, 32 9 -3 30
treatment, 33 3- 3 38
of anaphylaxis, 34 1
of food, ... for, 422
prognosis, 431
symptoms, 42 1-4 23
treatment, 42 7-4 31 , 428
education, 427
medication, 42 7-4 29
psychological and
behavioural therapy,
43 0-...
Evidence-based Cardiology – part 3 pptx
... (Ϫ20 33 )
CHD death Ϫ5 ( 37 –20)
CHAOS
17
2002 patients 1·4 800 IU/ Non-fatal MI 77 ( 53 89)
with CHD in 400 IU All-cause death Ϫ29 (Ϫ119–24)
the UK CV death Ϫ10 (Ϫ96 39 )
GISSI
18
11 32 4 3 5 30 0 ... status
Aromaa, 1994, 535 5 (55) 40–64
Depression 6·6 (me) Fatal CH
D (91) Age
1·95 (ss)
5
ϩϩ
Finland, Mini-
(GHQ -3 6
In those with no
Finland Health
and PSE)
pre-existing CVD: 3 36 (ss)...
Solar Cells Silicon Wafer Based Technologies Part 3 ppt
...
this work
Cell (33 °C)
G
sh
(Ω
-1
)
R
s
(Ω)
n
I
s
(µA)
I
ph
(A)
0.0186
0. 036 4
1.4 837
0 .32 23
0.7608
0.0094
0. 037 6
1.4841
0 .33 74
0.76 03
0.0114
0. 039 2
1.4425
0.2296 ... (45°C)
G
sh
(Ω
-1
)
R
s
(Ω)
n
I
s
(µA)
I
ph
(A)
0.00182
1.2057
48.450
3. 2876
1. 031 8
0.00145
1.1619
50.99
6 .39 86
1. 030
0.001445
1. 237 3...
Biomimetic Based Applications Part 3 ppt
... C(\7,:$="<(&+#%=+%#,&(89(@8#@7*# $3& amp;( ,3= "@&%<"+,2( $3( &$<$="(?,<(&78; $3? (>$8:$:,+$=(
"=+$B$+*( $3( @78+88E*? ,3& quot;+$ 83( 89(: 838 +,#@ ,3, &C(
J:ONZf J
4
WXO
N
NH
N
NH
CH
3
CH
3
CH
3
CH
3
CH
3
CH
3
CH
3
CH
3
N
N
NH
NH
CH
3
CH
3
O
O
OHOH
CH
3
CH
3
CH
3
OH
OH
CH
3
Homogeneous ...
1x10
-6...
Evidence based Dermatology - part 2 pptx
... RCTs),
1 23 130
erythromycin/zinc (three RCTs),
92, 131 , 132
2%
fusidic acid (two RCTs),
133 , 134
meclocycline,
135
metronidazole,
136
triclosan
137
and tetracycline
(three RCTs).
87–89
In the studies ... of
the six RCTs that presented data,
29 ,30 ,33 ,34 ,46
mean
percentage reductions in NIL ranged from 46%
to 83% in the 0·1% adapalene group and from
33 % to 83% in the 0·025%...
Evidence based Dermatology - part 3 pot
... Allergy Clin
Immunol
1999;
1 03
:125 38 .
148
Evidence- based Dermatology
20. Wahlgren CF, Hagermark O, Bergstrom R. The
antipruritic effect of a sedative and a non-sedative
antihistamine in atopic ... al
. 1998
(USA)
6
Twice-daily
tacrolimus ointment
0· 03% , 0·1% and
0 3%
v
vehicle alone
(emollients
and bath oils only)
Twice-daily
tacrolimus ointment
0· 03% , 0·1% and
0 3%
v
vehicle...
Evidence based Dermatology - part 8 pptx
... terpenoids.
12, 30 33
528
Evidence- based Dermatology
levels of immunoreactive β-melanocyte
stimulating hormone found normal levels in
patients taking oral contraceptives, some of
whom had melasma,
13
suggesting ... Dermatol
1986;
3
:34 4–8.
7. Taplin D, Castillero PM, Spiegel J
et al.
Malathion for
treatment of
Pediculus humanus var
. capitis infestation.
JAMA
1982;
247
:31 03...